Name: Latest research reports of Cipla Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 5
Author: ICICI Securities Limited

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer

1517.7000 4.70 (0.31%)

NSE Oct 03, 2025 15:31 PM

Volume: 1.1M

Cipla Ltd.

28 Oct 2023

1517.70

0.31%

Core business growth lifts margin to newer highs

Buy: Cipla Ltd.

Target

ICICI Securities Limited

Cipla continues to surprise us positively. Q2FY24 growth was led by core markets of India (up 10% YoY), US (~4% QoQ) and South Africa (15% YoY).

Cipla Ltd. is trading above its 200 day SMA of 1496.1